Cargando…

Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]

Detalles Bibliográficos
Autor principal: Xie, Mingrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448348/
https://www.ncbi.nlm.nih.gov/pubmed/36081761
http://dx.doi.org/10.2147/JIR.S387159
_version_ 1784784040408121344
author Xie, Mingrui
author_facet Xie, Mingrui
author_sort Xie, Mingrui
collection PubMed
description
format Online
Article
Text
id pubmed-9448348
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94483482022-09-07 Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter] Xie, Mingrui J Inflamm Res Letter Dove 2022-09-02 /pmc/articles/PMC9448348/ /pubmed/36081761 http://dx.doi.org/10.2147/JIR.S387159 Text en © 2022 Xie. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Letter
Xie, Mingrui
Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]
title Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]
title_full Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]
title_fullStr Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]
title_full_unstemmed Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]
title_short Long-Term Efficacy and Low Adverse Events of Methylprednisolone Pulses Combined to Low-Dose Glucocorticoids for Systemic Sclerosis: A Retrospective Clinical Study of 10 Years’ Follow-Up [Letter]
title_sort long-term efficacy and low adverse events of methylprednisolone pulses combined to low-dose glucocorticoids for systemic sclerosis: a retrospective clinical study of 10 years’ follow-up [letter]
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448348/
https://www.ncbi.nlm.nih.gov/pubmed/36081761
http://dx.doi.org/10.2147/JIR.S387159
work_keys_str_mv AT xiemingrui longtermefficacyandlowadverseeventsofmethylprednisolonepulsescombinedtolowdoseglucocorticoidsforsystemicsclerosisaretrospectiveclinicalstudyof10yearsfollowupletter